An informed public,
a strengthened democracy.
FOIA to the Food and Drug Administration (FDA) seeking records sufficient to identify the date Gilead submitted its request for orphan-drug designation for remdesivir as a treatment for COVID-19. HHS-FDA-20-0718
Part of Investigation: